QUESTION: Does 68Ga-PSMA-11 PET/CT improve initial staging detection of metastatic disease and influence surgical eligibility in patients with high- or unfavorable intermediate-risk PCa in a worldwide scenario? This evidence concerns the gene FOLH1 and posterior cortical atrophy.